Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Non-Current Deferred Tax Liability (2016 - 2018)

Armata Pharmaceuticals' Non-Current Deferred Tax Liability history spans 6 years, with the latest figure at $1.1 million for Q3 2018.

  • For Q3 2018, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $1.1 million; the TTM value through Sep 2018 reached $1.1 million, changed 0.0%, while the annual FY2017 figure was $1.1 million, 53.16% down from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2018 was $1.1 million at Armata Pharmaceuticals, roughly flat from $1.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $3.1 million in Q1 2014 and bottomed at $1.1 million in Q2 2017.
  • The 5-year median for Non-Current Deferred Tax Liability is $3.0 million (2016), against an average of $2.4 million.
  • The largest annual shift saw Non-Current Deferred Tax Liability changed 0.0% in 2014 before it plummeted 61.83% in 2017.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $3.1 million in 2014, then changed by 0.0% to $3.1 million in 2015, then fell by 20.44% to $2.4 million in 2016, then plummeted by 53.16% to $1.1 million in 2017, then changed by 0.0% to $1.1 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Non-Current Deferred Tax Liability are $1.1 million (Q3 2018), $1.1 million (Q2 2018), and $1.1 million (Q1 2018).